He Ren

Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy

Xiao Zhao, Keni Yang, Ruifang Zhao et al. · Biomaterials · 2016 · 254 citations

Pharmacy, Oncology, Pharmaceutics +16

Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer

Xiao Zhao, Feng Li, Yiye Li et al. · Biomaterials · 2015 · 245 citations

Pharmacy, Oncology, Pharmaceutics +17

Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma

Xiuchao Wang, Mingxiao Lang, Tiansuo Zhao et al. · Oncogene · 2016 · 235 citations · Full text

Medicine, Cancer Biology, Oncology +16

Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism

Ke Chen, Ding Wang, Wei Du et al. · Clinical Immunology · 2010 · 198 citations

Life Sciences, Cell Biology, Immunology +9

Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura.

Tingting Wang, Hui Zhao, He Ren et al. · PubMed · 2005 · 165 citations

Life Sciences, Immunology, Pathology +17